Real-world evidence: Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) in chronic obstructive pulmonary disease
2 questions · 1 source
Real-world evidence
Is an early Trelegy start after a first COPD exacerbation linked to fewer exacerbations?
“Results are descriptive only.” (opens the source at this quote in a new tab)
On the page, select: Real-world study description and considerations1
On the page, select: Real-world study description and considerations1
On the page, select: Real-world study description and considerations1
On the page, select: Real-world study description and considerations1
On the page, select: Real-world study description and considerations1
Is an early Trelegy start linked to a later next COPD exacerbation?
“Results are descriptive only.” (opens the source at this quote in a new tab)
On the page, select: Real-world study description and considerations1
On the page, select: Real-world study description and considerations1
On the page, select: Real-world study description and considerations1